These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 2468451)

  • 21. Mass spectrometric mapping of protein epitope structures of myocardial infarct markers myoglobin and troponin T.
    Macht M; Fiedler W; Kürzinger K; Przybylski M
    Biochemistry; 1996 Dec; 35(49):15633-9. PubMed ID: 8961925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological characterization of an immunomodulatory epitope in S-antigen/arrestin with a sequence motif common to tumor necrosis factor alpha.
    Stiemer RH; Gausepohl H; Mirshahi M; de Kozak Y; Kraft M; Faure JP; Frank RW
    Immunol Lett; 1992 May; 32(3):233-40. PubMed ID: 1379981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structure-function studies of S-antigen: use of proteases to reveal a dominant uveitogenic site.
    Dua HS; Hossain P; Brown PA; McKinnon A; Forrester JV; Gregerson DS; Donoso LA
    Autoimmunity; 1991; 10(2):153-63. PubMed ID: 1723632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of epitopes associated with hCG and the beta hCG carboxyl terminus by monoclonal antibodies produced against a synthetic peptide.
    Bidart JM; Ozturk M; Bellet DH; Jolivet M; Gras-Masse H; Troalen F; Bohuon CJ; Wands JR
    J Immunol; 1985 Jan; 134(1):457-64. PubMed ID: 2578049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S-antigen: identification of the MAbA9-C6 monoclonal antibody binding site and the uveitopathogenic sites.
    Donoso LA; Merryman CF; Shinohara T; Dietzschold B; Wistow G; Craft C; Morley W; Henry RT
    Curr Eye Res; 1986 Dec; 5(12):995-1004. PubMed ID: 3492336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epitope mapping of form-specific and nonspecific antibodies to acetylcholinesterase.
    Wasserman L; Doctor BP; Gentry MK; Taylor P
    J Neurochem; 1993 Dec; 61(6):2124-32. PubMed ID: 7504082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies against an identical short peptide sequence shared by two unrelated proteins.
    Schulze-Gahmen U; Wilson IA
    Pept Res; 1989; 2(5):322-31. PubMed ID: 2485209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiotypic characterisation of monoclonal antibodies with restricted epitope specificity for retinal S-antigen.
    Suleyman S; Kasp E; Ellis B; Banga JP; Dumonde DC
    Autoimmunity; 1991; 9(2):91-7. PubMed ID: 1718460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B-cell epitopes of the allergen Chi t 1.01: peptide mapping of epitopes recognized by rabbit, murine, and human antibodies.
    van Kampen V; Liebers V; Sander I; Chen Z; Baur X; Raulf-Heimsoth M; Falkenberg FW
    Allergy; 2001 Feb; 56(2):118-25. PubMed ID: 11167371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mapping the binding of monoclonal antibodies to histone H5.
    Mendelson E; Smith BJ; Bustin M
    Biochemistry; 1984 Jul; 23(15):3466-71. PubMed ID: 6205691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A common epitope on human tumor necrosis factor alpha and the autoantigen 'S-antigen/arrestin' induces TNF-alpha production.
    Stiemer RH; Westenfelder U; Gausepohl H; Mirshahi M; Gundt A; Frank RW; Männel DN
    J Autoimmun; 1992 Feb; 5(1):15-26. PubMed ID: 1373060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epitope specificity of 30 monoclonal antibodies against cytokeratin antigens: the ISOBM TD5-1 Workshop.
    Stigbrand T; Andrés C; Bellanger L; Bishr Omary M; Bodenmüller H; Bonfrer H; Brundell J; Einarsson R; Erlandsson A; Johansson A; Leca JF; Levi M; Meier T; Nap M; Nustad K; Seguin P; Sjödin A; Sundström B; van Dalen A; Wiebelhaus E; Wiklund B; Arlestig L; Hilgers J
    Tumour Biol; 1998; 19(2):132-52. PubMed ID: 9486565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies to cyanogen bromide fragments of glycophorin A.
    Barsoum AL; Bhavanandan VP; Davidson EA
    Mol Immunol; 1985 Apr; 22(4):361-7. PubMed ID: 2412108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of visual arrestin (S-antigen) in retinal pigmented epithelial cells.
    Nicolas C; Ghedira I; Stiemer R; Teufel B; Hecquet C; Faure JP; Mirshahi M
    Curr Eye Res; 2000 Sep; 21(3):677-83. PubMed ID: 11120555
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of antibody epitopes in the CB-11 peptide of bovine type II collagen recognized by sera from arthritis-susceptible and -resistant rhesus monkeys.
    Turner S; Bakker NP; t Hart BA; Holt PJ; Morgan K
    Clin Exp Immunol; 1994 May; 96(2):275-80. PubMed ID: 7514515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibodies to the myogenic regulatory protein MyoD1: epitope mapping and diagnostic utility.
    Dias P; Parham DM; Shapiro DN; Tapscott SJ; Houghton PJ
    Cancer Res; 1992 Dec; 52(23):6431-9. PubMed ID: 1384962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).
    Boshuizen RS; Marsden C; Turkstra J; Rossant CJ; Slootstra J; Copley C; Schwamborn K
    MAbs; 2014; 6(6):1415-24. PubMed ID: 25484047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
    Gregerson DS; Obritsch WF; Donoso LA
    J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conformational differences between surface-bound and fluid-phase complement-component-C3 fragments. Epitope mapping by cDNA expression.
    Nilsson B; Grossberger D; Nilsson Ekdahl K; Riegert P; Becherer DJ; Nilsson UR; Lambris JD
    Biochem J; 1992 Mar; 282 ( Pt 3)(Pt 3):715-21. PubMed ID: 1372802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.